To date, the only Food and Drug Administration (FDA)-approved physiopathological therapy for ischemic stroke remains the use of tissue plasminogen activator (tPA), and mechanical clot retrieval to recanalize occluded blood vessels. Here, PLAT is linked to ischemic stroke.